136 related articles for article (PubMed ID: 38469918)
1. Dendritic Polymer-Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response.
Zhang Y; Fang Z; Pan D; Li Y; Zhou J; Chen H; Li Z; Zhu M; Li C; Qin L; Ren X; Gong Q; Luo K
Adv Mater; 2024 Jun; 36(25):e2401304. PubMed ID: 38469918
[TBL] [Abstract][Full Text] [Related]
2. Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system.
Chen B; Dai W; Mei D; Liu T; Li S; He B; He B; Yuan L; Zhang H; Wang X; Zhang Q
J Control Release; 2016 Nov; 241():68-80. PubMed ID: 27641831
[TBL] [Abstract][Full Text] [Related]
3. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
Guo J; Zeng H; Chen Y
Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
[TBL] [Abstract][Full Text] [Related]
4. Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.
Chen E; Han S; Song B; Xu L; Yuan H; Liang M; Sun Y
Int J Nanomedicine; 2020; 15():6311-6324. PubMed ID: 32922003
[TBL] [Abstract][Full Text] [Related]
5. IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration.
Yang W; Chen Z; Qu L; Zhang C; Chen H; Zheng J; Chen W; Tan X; Shi C
Curr Cancer Drug Targets; 2024; 24(6):642-653. PubMed ID: 38310462
[TBL] [Abstract][Full Text] [Related]
6. Emerging strategies against tumor-associated fibroblast for improved the penetration of nanoparticle into desmoplastic tumor.
Yunna C; Mengru H; Fengling W; Lei W; Weidong C
Eur J Pharm Biopharm; 2021 Aug; 165():75-83. PubMed ID: 33991610
[TBL] [Abstract][Full Text] [Related]
7. Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts.
Qiu ZW; Zhong YT; Lu ZM; Yan N; Kong RJ; Huang JQ; Li ZF; Nie JM; Li R; Cheng H
ACS Nano; 2024 Apr; 18(13):9713-9735. PubMed ID: 38507590
[TBL] [Abstract][Full Text] [Related]
8. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
9. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
Xue X; Wang X; Pang M; Yu L; Qian J; Li X; Tian M; Lu C; Xiao C; Liu Y
J Nanobiotechnology; 2024 Apr; 22(1):196. PubMed ID: 38644492
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions.
Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D
Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584
[TBL] [Abstract][Full Text] [Related]
11. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
12. Transformable nanoparticles triggered by cancer-associated fibroblasts for improving drug permeability and efficacy in desmoplastic tumors.
Hou L; Chen D; Hao L; Tian C; Yan Y; Zhu L; Zhang H; Zhang Y; Zhang Z
Nanoscale; 2019 Nov; 11(42):20030-20044. PubMed ID: 31612175
[TBL] [Abstract][Full Text] [Related]
13. Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor.
Pang N; Li J; Sun A; Yang Z; Cheng S; Qi XR
Int J Nanomedicine; 2018; 13():5971-5990. PubMed ID: 30323586
[TBL] [Abstract][Full Text] [Related]
14. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
Ai W; Liu T; Lv C; Feng X; Wang Q
Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
[TBL] [Abstract][Full Text] [Related]
16. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models.
Almuqbil RM; Heyder RS; Bielski ER; Durymanov M; Reineke JJ; da Rocha SRP
Mol Pharm; 2020 May; 17(5):1648-1662. PubMed ID: 32227969
[TBL] [Abstract][Full Text] [Related]
18. Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect.
Luo Q; Lin L; Huang Q; Duan Z; Gu L; Zhang H; Gu Z; Gong Q; Luo K
Acta Biomater; 2022 Apr; 143():320-332. PubMed ID: 35235863
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the tumor penetration of multiarm polymers by collagenase modification.
Yu B; Wang W; Zhang Y; Sun Y; Li C; Liu Q; Zhen X; Jiang X; Wu W
Biomater Sci; 2024 Apr; 12(9):2302-2311. PubMed ID: 38497169
[TBL] [Abstract][Full Text] [Related]
20. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]